Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
QuintilesIMS
Daiichi Sankyo
McKinsey
US Department of Justice
Cipla
Baxter
Covington
Dow
Julphar

Generated: January 16, 2018

DrugPatentWatch Database Preview

DEXRAZOXANE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Dexrazoxane Hydrochloride, and what generic alternatives are available?

Dexrazoxane Hydrochloride is a drug marketed by Gland Pharma Ltd, Mylan Institutional, and West-ward Pharms Int. and is included in three NDAs.

The generic ingredient in DEXRAZOXANE HYDROCHLORIDE is dexrazoxane hydrochloride. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dexrazoxane hydrochloride profile page.
Drug patent expirations by year for DEXRAZOXANE HYDROCHLORIDE
Pharmacology for DEXRAZOXANE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for DEXRAZOXANE HYDROCHLORIDE

US Patents and Regulatory Information for DEXRAZOXANE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gland Pharma Ltd DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 207321-001 Nov 28, 2016 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 076068-001 Sep 28, 2004 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Institutional DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 200752-001 Oct 19, 2011 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Institutional DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 200752-002 Oct 19, 2011 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 076068-002 Sep 28, 2004 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Citi
US Department of Justice
Queensland Health
Chubb
Federal Trade Commission
Baxter
Covington
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot